We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Amryt Pharma chairman makes share purchase

Mon, 15th Mar 2021 16:38

(Sharecast News) - Amryt Pharma revealed on Monday that chairman Ram Stafford had acquired 300,100 ordinary shares in the AIM-listed commercial-stage biopharmaceutical company.
Stafford, who previously headed up Sudocrem owner Tosara Group, purchased the shares on Friday at an average price of 200.0p per share, for a total value of £600,200.

Last week, Amryt announced the signing of a distribution agreement with Medison Pharma to distribute its Myalepta product in Canada.

Amryt said the agreement completed its multi-regional distribution deals with Medison, first announced in February, to distribute Myalepta and Lojuxta in Israel and Juxtapid in Canada.

As of 1645 GMT, Amryt shares were up 3.54% at 205.0p.

Top Director Buys

Amryt Pharma (AMYT)
Director name: Stafford,Ray
Amount purchased: 300,100 @ 200.00p
Value: £600,200.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount purchased: 224,489 @ 97.58p
Value: £219,056.36

Newriver Reit (NRR)
Director name: Davies,Mark
Amount purchased: 185,000 @ 96.20p
Value: £177,970.00

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 282,029 @ 51.11p
Value: £144,145.02

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 250,000 @ 51.35p
Value: £128,374.99

Edinburgh Worldwide Inv Trust (EWI)
Director name: Wilson,Mungo
Amount purchased: 35,613 @ 350.50p
Value: £124,823.57

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 95,000,000 @ 0.09p
Value: £86,402.50

Serco Group (SRP)
Director name: Lodge,Tim
Amount purchased: 40,000 @ 127.20p
Value: £50,880.00

Frenkel Topping Group (FEN)
Director name: Mills,Christopher
Amount purchased: 100,000 @ 45.00p
Value: £45,000.00

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 37,000,000 @ 0.09p
Value: £31,524.00

F&c Investment Trust (FCIT)
Director name: Joy,Tom
Amount purchased: 3,500 @ 788.86p
Value: £27,610.10

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 18,000,000 @ 0.09p
Value: £16,830.00

Lxi Reit (LXI)
Director name: Dimond,Patricia
Amount purchased: 8,005 @ 124.92p
Value: £9,999.53

Rockfire Resources (ROCK)
Director name: Walley,Nicholas
Amount purchased: 536,000 @ 0.95p
Value: £5,092.00

F&c Investment Trust (FCIT)
Director name: Ecsery,Francesca
Amount purchased: 380 @ 783.48p
Value: £2,977.24



Top Director Sells

Pagegroup (PAGE)
Director name: Ingham,Stephen
Amount sold: 41,638 @ 480.10p
Value: £199,904.04

Newriver Reit (NRR)
Director name: Davies,Mark
Amount sold: 185,000 @ 96.20p
Value: £177,970.00

Dukemount Capital (DKE)
Director name: Dart,Geoffrey
Amount sold: 27,000,000 @ 0.60p
Value: £162,000.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount sold: 133,745 @ 97.20p
Value: £130,000.14

Pagegroup (PAGE)
Director name: Stagg ,Kelvin
Amount sold: 20,774 @ 480.10p
Value: £99,735.98

Cropper (james) (CRPR)
Director name: Maddock,Isabelle
Amount sold: 500 @ 1,100.00p
Value: £5,500.00

More News
11 Jan 2022 14:39

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

Read more
22 Nov 2021 11:37

Amryt to delist from AIM, concentrate on Nasdaq trading

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced its intention to cancel its shares from trading on AIM on Monday, with effect on 11 January.

Read more
9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Read more
19 Oct 2021 15:54

Amryt Pharma granted another two US patents

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma updated the market on patents for its lead development candidate 'Oleogel-S10' on Tuesday, as well as its recently-acquired and third commercial product 'Mycapssa'.

Read more
14 Sep 2021 07:32

IN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisition

IN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisition

Read more
6 Aug 2021 14:41

IN BRIEF: Amryt hikes guidance on record second quarter results

IN BRIEF: Amryt hikes guidance on record second quarter results

Read more
6 Aug 2021 12:02

Record second quarter sees Amryt lift guidance further

(Sharecast News) - Amryt Pharma reported record second quarter results on Friday, raising its full-year guidance, as revenue in the three months ended 30 June came in at $62.8m, up from $46.2m year-on-year.

Read more
29 Jul 2021 17:10

EXECUTIVE CHANGES: HL CFO to depart; Novacyt hires CEO from Amryt

EXECUTIVE CHANGES: HL CFO to depart; Novacyt hires CEO from Amryt

Read more
17 Jun 2021 14:34

Cathal Friel-led Poolbeg Pharma set to float on AIM

(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising the funds needed to develop its product pipeline.

Read more
3 Jun 2021 19:20

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

Read more
3 Jun 2021 11:26

FDA grants Amryt's Oleogel-S10 priority review status

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced on Thursday that the United States Food and Drug Administration (FDA) has granted priority review status for the new drug application for 'Oleogel-S10', for the treatment of epidermolysis bullosa (EB).

Read more
2 Jun 2021 19:10

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
6 Apr 2021 14:54

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

Read more
31 Mar 2021 11:50

Amryt completes rolling FDA submission for Oleogel-S10

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has completed the rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for 'Oleogel-S10', it announced on Wednesday, for the potential treatment of cutaneous manifestations of junctional and dystrophic epidermolysis bullosa (EB).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.